SynBioBeta Speaker
Jacob Glanville
CEO
Centivax
YEAR
25
May 2025, SynBioBeta
Speaker
Jacob Glanville is an Entrepreneur and Computational Immuno-Engineer. As Founder, CEO and President of Centivax, he enjoys collaborating with multiple partners to generate exciting new technologies in biomedicine.
SynBioBeta 2025 - Session Speaker
Universal Immunity
What if immunity wasn’t just personal—it was programmable, portable, and universal? This session explores the cutting edge of immunological engineering, converging rapid-response vaccine platforms, AI-designed antibody libraries, and global health deployment systems to build a world no longer vulnerable to pandemics. From biofoundry-enabled vaccine design to distributed manufacturing and last-mile delivery, the conversation will examine the technological, clinical, and infrastructural shifts needed to create scalable immune resilience—across pathogens, across borders, and across populations. Join us as we reimagine the immune system not as a biological lottery, but as an engineered global asset.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,595
USD
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Before Midnight Thu, Dec 4
Regular Rate
$1,995
Purchase Pass
Purchase Pass
BLACK FRIDAY DEAL
Buy 1 Conference Pass, Get 1 Expo Pass Free
Conference Pass
1,595
USD
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Before Midnight Thu, Dec 4
Regular Rate
$1,995
Purchase Pass
Purchase Pass
BLACK FRIDAY DEAL
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
2026
Event Updates